Pub Date : 2025-12-24eCollection Date: 2025-01-01DOI: 10.22088/cjim.16.3.451
Heydar Ali Balou, Farahnaz Joukar, Mahdi Orang Goorabzarmakhi, Milad Shahdkar, Soheil Hassanipour, Saman Maroufizadeh, Mehrnaz Asgharnezhad, Paridokht Karimian, Fariborz Mansour-Ghanaei
Background: Early colorectal cancer (CRC) detection helps reduce the mortality rate. This study aimed to investigate colon lesions in individuals with positive and negative fecal immunochemical test (FIT) results among the (PERSIAN) Guilan cohort study (PGCS) population.
Methods: This cross-sectional study was conducted on 1158 participants over 50 who were volunteers for the FIT stool test at the Endoscopy Department of Razi Hospital, Rasht, Iran, from 2021 to 2022. The FIT test was screened for all participants, and for 172 individuals (86 individuals from each group with positive and negative FIT results), a colonoscopy was performed to investigate the colon lesions. Demographic/clinical characteristics, FIT results, colonoscopy findings, and the Bristol Stool Chart were completed. All data were analyzed using SPSS Version 16, considering a significant level<0.05.
Results: Out of 1,158 participants, 86 had positive FIT results, and 172 (52.3%) were females. The colonoscopy results showed that 34.3% of the patients had colon lesions. Individuals with positive FIT exhibited a significantly higher prevalence of colon lesions (p<0.001). No statistically significant differences were observed between positive and negative FIT results, demographic and clinical characteristics, and the location of lesions in individuals with colon lesions (p>0.05). Moreover, there was a significant difference in pathological findings and the presence of adenomatous polyps regarding the FIT results (p<0.001).
Conclusion: The effectiveness of FIT in the initial stages of screening for early lesion detection is considerable, especially for individuals with upper age.
背景:早期结直肠癌(CRC)检测有助于降低死亡率。本研究旨在调查(波斯)Guilan队列研究(PGCS)人群中粪便免疫化学试验(FIT)结果阳性和阴性个体的结肠病变。方法:本横断面研究对1158名50岁以上的参与者进行了研究,这些参与者是2021年至2022年期间在伊朗Rasht Razi医院内窥镜科参加FIT粪便检查的志愿者。对所有参与者进行FIT测试筛选,对172人(每组86人,FIT结果为阳性和阴性)进行结肠镜检查以调查结肠病变。完成人口统计学/临床特征、FIT结果、结肠镜检查结果和Bristol大便图。所有数据均采用SPSS Version 16进行分析,考虑显著性水平。结果:在1158名参与者中,86名FIT结果阳性,其中172名(52.3%)为女性。结肠镜检查结果显示34.3%的患者有结肠病变。FIT阳性的个体结肠病变的患病率明显更高(p0.05)。此外,FIT结果在病理表现和是否存在腺瘤性息肉方面存在显著差异(p结论:FIT在筛查早期病变发现的初始阶段的有效性是相当大的,特别是对于年龄较大的个体。
{"title":"Colon lesions in elderly individuals with positive and negative fecal immunochemical test results among PERSIAN Guilan cohort study (PGCS) population.","authors":"Heydar Ali Balou, Farahnaz Joukar, Mahdi Orang Goorabzarmakhi, Milad Shahdkar, Soheil Hassanipour, Saman Maroufizadeh, Mehrnaz Asgharnezhad, Paridokht Karimian, Fariborz Mansour-Ghanaei","doi":"10.22088/cjim.16.3.451","DOIUrl":"10.22088/cjim.16.3.451","url":null,"abstract":"<p><strong>Background: </strong>Early colorectal cancer (CRC) detection helps reduce the mortality rate. This study aimed to investigate colon lesions in individuals with positive and negative fecal immunochemical test (FIT) results among the (PERSIAN) Guilan cohort study (PGCS) population<b>.</b></p><p><strong>Methods: </strong>This cross-sectional study was conducted on 1158 participants over 50 who were volunteers for the FIT stool test at the Endoscopy Department of Razi Hospital, Rasht, Iran, from 2021 to 2022. The FIT test was screened for all participants, and for 172 individuals (86 individuals from each group with positive and negative FIT results), a colonoscopy was performed to investigate the colon lesions. Demographic/clinical characteristics, FIT results, colonoscopy findings, and the Bristol Stool Chart were completed. All data were analyzed using SPSS Version 16, considering a significant level<0.05<b>.</b></p><p><strong>Results: </strong>Out of 1,158 participants, 86 had positive FIT results, and 172 (52.3%) were females. The colonoscopy results showed that 34.3% of the patients had colon lesions. Individuals with positive FIT exhibited a significantly higher prevalence of colon lesions (p<0.001). No statistically significant differences were observed between positive and negative FIT results, demographic and clinical characteristics, and the location of lesions in individuals with colon lesions (p>0.05). Moreover, there was a significant difference in pathological findings and the presence of adenomatous polyps regarding the FIT results (p<0.001).</p><p><strong>Conclusion: </strong>The effectiveness of FIT in the initial stages of screening for early lesion detection is considerable, especially for individuals with upper age.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 3","pages":"451-457"},"PeriodicalIF":1.0,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329380/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144944094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
[This corrects the article on p. 690 in vol. 15, PMID: 39359446.].
[这更正了第15卷第690页的文章,PMID: 39359446]。
{"title":"Erratum: Author Correction: A comparative study of the local effect of tranexamic acid and phenylephrine on the amount of bleeding in rhinoplasty: A randomized clinical trial.","authors":"Hooshang Akbari, Ebrahim Nasiri Formi, Abbas Alipour, Hamed Delam, Esmaeil Kavi, Behrooz Gandomi, Negar Shahkarami","doi":"10.22088/cjim.16.4.813","DOIUrl":"https://doi.org/10.22088/cjim.16.4.813","url":null,"abstract":"<p><p>[This corrects the article on p. 690 in vol. 15, PMID: 39359446.].</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"813"},"PeriodicalIF":1.0,"publicationDate":"2025-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694928/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145740768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-20eCollection Date: 2025-01-01DOI: 10.22088/cjim.16.4.807
Petar Avramovski, Zaklina Servini, Maja Avramovska, Kosta Sotiroski, Aleksandra Arandjelovic, Aleksandra Servini, Vesna Siklovska, Stefan Talev, Irena Trajcevska
Background: The Chiari network consists of movable, mesh-like structures occasionally observed in the right atrium proximate to the openings of the inferior vena cava and coronary sinus.
Case presentation: This case discusses a 75-year-old male initially suspected to have acute pulmonary thromboembolism, but we misdiagnosed the Chiari network as a thrombus in the right atrium. Subsequent echocardiography revealed a Chiari network in the right atrium. Accurate identification using transthoracic echocardiography, Doppler echocardiography, is crucial.
Conclusion: Accurate identification of the Chiari network is essential for optimal patient care. Thorough evaluation is crucial in cases suggestive of acute pulmonary thromboembolism or right atrium thrombus.
{"title":"Unveiling the Chiari network: A case report of misdiagnosis mimicking pulmonary embolism and right atrium thrombus.","authors":"Petar Avramovski, Zaklina Servini, Maja Avramovska, Kosta Sotiroski, Aleksandra Arandjelovic, Aleksandra Servini, Vesna Siklovska, Stefan Talev, Irena Trajcevska","doi":"10.22088/cjim.16.4.807","DOIUrl":"10.22088/cjim.16.4.807","url":null,"abstract":"<p><strong>Background: </strong>The Chiari network consists of movable, mesh-like structures occasionally observed in the right atrium proximate to the openings of the inferior vena cava and coronary sinus.</p><p><strong>Case presentation: </strong>This case discusses a 75-year-old male initially suspected to have acute pulmonary thromboembolism, but we misdiagnosed the Chiari network as a thrombus in the right atrium. Subsequent echocardiography revealed a Chiari network in the right atrium. Accurate identification using transthoracic echocardiography, Doppler echocardiography, is crucial.</p><p><strong>Conclusion: </strong>Accurate identification of the Chiari network is essential for optimal patient care. Thorough evaluation is crucial in cases suggestive of acute pulmonary thromboembolism or right atrium thrombus.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"807-812"},"PeriodicalIF":1.0,"publicationDate":"2025-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694807/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145741312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: This case of pancytopenia due to hypothyroidism and B12 deficiency is rare and severe as a reminder that, upon diagnosis of pancytopenia, endocrine disorders such as secondary thyroid hormone deficiency may need to be considered as a potential cause.
Case presentation: A 38-year-old male presented with progressive weakness, lethargy, and anorexia. Initial labs revealed severe pancytopenia, prompting a hematological workup. Bone marrow aspiration ruled out acute leukemia. Further investigations identified severe primary hypothyroidism (TSH: 200 mIU/L) and vitamin B12 deficiency as the underlying causes, after excluding other common etiologies. Treatment with levothyroxine and vitamin B12 was initiated. The patient showed a rapid and significant hematological response, with all cell lines improving and approaching normal ranges on follow-up, confirming the diagnosis.
Conclusion: In this patient, after the diagnosis of hypothyroidism and receiving levothyroxine, we saw a better stability of the improvement of the patient's symptoms and a further improvement in the number of any blood cell lines chiefly platelet which is one of the regulators of the coagulation pathway, and its deficiency increase the risk of bleeding.
{"title":"Pancytopenia in the context of hypothyroidism and B12 deficiency: A case report and review literature.","authors":"Fatemeh Karimpour, Mohammadreza Valizadeh, Hanieh Ranjbar, Zeinab Vosough","doi":"10.22088/cjim.16.4.801","DOIUrl":"10.22088/cjim.16.4.801","url":null,"abstract":"<p><strong>Background: </strong>This case of pancytopenia due to hypothyroidism and B12 deficiency is rare and severe as a reminder that, upon diagnosis of pancytopenia, endocrine disorders such as secondary thyroid hormone deficiency may need to be considered as a potential cause.</p><p><strong>Case presentation: </strong>A 38-year-old male presented with progressive weakness, lethargy, and anorexia. Initial labs revealed severe pancytopenia, prompting a hematological workup. Bone marrow aspiration ruled out acute leukemia. Further investigations identified severe primary hypothyroidism (TSH: 200 mIU/L) and vitamin B12 deficiency as the underlying causes, after excluding other common etiologies. Treatment with levothyroxine and vitamin B12 was initiated. The patient showed a rapid and significant hematological response, with all cell lines improving and approaching normal ranges on follow-up, confirming the diagnosis.</p><p><strong>Conclusion: </strong>In this patient, after the diagnosis of hypothyroidism and receiving levothyroxine, we saw a better stability of the improvement of the patient's symptoms and a further improvement in the number of any blood cell lines chiefly platelet which is one of the regulators of the coagulation pathway, and its deficiency increase the risk of bleeding.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"801-806"},"PeriodicalIF":1.0,"publicationDate":"2025-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694780/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145741206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-19eCollection Date: 2025-01-01DOI: 10.22088/cjim.16.4.775
Mansour Rezaei, Maryam Montaseri, Shayan Mostafaei, Armin Khayati, Mohammad Taheri
Background: The aim of this study was developing and comparative analyzing prediction models using a Cox proportional hazards model with and without frailty, random survival forests (RSF) and survival support vector regression (SVR).
Methods: In this study, 2800 patients with STEMI have been used and two machine learning methods for survival analysis have been applied: RSF and SVR, then the Cox model with and without frailty has been employed. The main outcome was 1-year mortality after STEMI. In this study, 16 variables have missing data. After applying four multiple imputation via chained equations methods, the "Sample" algorithm was selected as the appropriate model with complete data and the modeling process was continued with this data and Hazard Ratio (HR) were calculated.
Results: Overall, 1628 (58.1%) patients received primary percutaneous coronary intervention and 737 (26.3%) received thrombolytic therapy. Based on the experimental results, between all the models, the Cox with frailty model performed the best, with the highest overall C-index (0.891) and time-dependent area under the curve (0.9134) and the least Brier score (0.0458). Ever smoking (HR= 1.46), systolic blood pressure (HR= 0.98), left ventricular ejection fraction (HR= 0.96), glomerular filtration rate (HR= 0.96), and reperfusion therapy (No reperfusion HR= 2.71) independently associated with 1-year mortality of STEMI patients.
Conclusion: The findings suggest that there are advantages in developing frailty models further than the fundamental Cox proportional hazards regression for estimating the likelihood of survival for STEMI patients to account for the unobserved heterogeneity in grouped observations.
{"title":"One-year survival prediction models following ST-elevation myocardial infarction: A comparative analysis of the Cox Frailty Model and machine learning.","authors":"Mansour Rezaei, Maryam Montaseri, Shayan Mostafaei, Armin Khayati, Mohammad Taheri","doi":"10.22088/cjim.16.4.775","DOIUrl":"10.22088/cjim.16.4.775","url":null,"abstract":"<p><strong>Background: </strong>The aim of this study was developing and comparative analyzing prediction models using a Cox proportional hazards model with and without frailty, random survival forests (RSF) and survival support vector regression (SVR).</p><p><strong>Methods: </strong>In this study, 2800 patients with STEMI have been used and two machine learning methods for survival analysis have been applied: RSF and SVR, then the Cox model with and without frailty has been employed. The main outcome was 1-year mortality after STEMI. In this study, 16 variables have missing data. After applying four multiple imputation via chained equations methods, the \"Sample\" algorithm was selected as the appropriate model with complete data and the modeling process was continued with this data and Hazard Ratio (HR) were calculated.</p><p><strong>Results: </strong>Overall, 1628 (58.1%) patients received primary percutaneous coronary intervention and 737 (26.3%) received thrombolytic therapy. Based on the experimental results, between all the models, the Cox with frailty model performed the best, with the highest overall C-index (0.891) and time-dependent area under the curve (0.9134) and the least Brier score (0.0458). Ever smoking (HR= 1.46), systolic blood pressure (HR= 0.98), left ventricular ejection fraction (HR= 0.96), glomerular filtration rate (HR= 0.96), and reperfusion therapy (No reperfusion HR= 2.71) independently associated with 1-year mortality of STEMI patients.</p><p><strong>Conclusion: </strong>The findings suggest that there are advantages in developing frailty models further than the fundamental Cox proportional hazards regression for estimating the likelihood of survival for STEMI patients to account for the unobserved heterogeneity in grouped observations.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"775-790"},"PeriodicalIF":1.0,"publicationDate":"2025-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694771/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145741225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Cancers of the brain and central nervous system, with more than 250,000 deaths in 2020 and an age-adjusted mortality rate of 3.05 per 100,000, rank twelfth in mortality among various cancers. Our study aimed to investigate the crude rate, age-standardized mortality rate (ASMR) and the trends of brain and CNS malignancies over nine years in northern Iran.
Methods: This cross-sectional study conducted a thorough analysis of mortality caused by brain and CNS cancers in Babol between the years 2013 and 2021. Death registration and classification systems at Babol University of Medical Sciences were used to collect the cause-of-death data. A census sampling method was used to determine the number of brain and CNS cancers deaths. All analyses were done using SPSS Version 22 and STATA Version 14. The significance level was set at (p<0.05). The crude and age-standardized mortality rate was calculated. The Cochran-Armitage Trend Test was utilized to determine the mortality trend.
Results: The crude rates and ASMRs for brain and CNS cancers increased, from 3.3 and 3.2 per 100,000 people in 2013 to 7.0 and 6.3 per 100,000 in 2021, respectively (p < 0.001). Additionally, over the nine years, an increasing trend was explicitly observed for brain cancer (p < 0.001), while the trends for other cancers remained stable.
Conclusion: The ASMR and the trend of brain and CNS cancers are on the rise. This study's findings could be beneficial for designing monitoring programs and investigating cancer risk factors.
背景:2020年,脑和中枢神经系统癌症死亡人数超过25万,年龄调整死亡率为3.05 / 10万,在各种癌症死亡率中排名第十二。本研究旨在调查伊朗北部地区9年来脑和中枢神经系统恶性肿瘤的粗死亡率、年龄标准化死亡率(ASMR)和趋势。方法:本横断面研究对2013年至2021年间巴博尔地区脑癌和中枢神经系统癌引起的死亡率进行了全面分析。使用巴博尔医学科学大学的死亡登记和分类系统收集死因数据。采用人口普查抽样方法确定脑癌和中枢神经系统癌死亡人数。所有分析均使用SPSS Version 22和STATA Version 14完成。结果:脑癌和中枢神经系统癌的粗发病率和asmr分别从2013年的每10万人3.3和3.2增加到2021年的每10万人7.0和6.3 (p < 0.001)。此外,在过去的九年里,脑癌的发病率明显呈上升趋势(p < 0.001),而其他癌症的发病率趋势保持稳定。结论:ASMR呈上升趋势,脑癌和中枢神经系统癌呈上升趋势。这项研究的发现可能有助于设计监测程序和调查癌症风险因素。
{"title":"Mortality trends of brain and central nervous system cancers in Babol, northern Iran (2013-2021).","authors":"Mohsen Karami, Amir-Hossein Lashkarbolouki, Pouyan Ebrahimi, Seyed-Hossein Hosseini-Berneti, Mohammad-Amin Ghezel, Hossein-Ali Nikbakht","doi":"10.22088/cjim.16.4.791","DOIUrl":"10.22088/cjim.16.4.791","url":null,"abstract":"<p><strong>Background: </strong>Cancers of the brain and central nervous system, with more than 250,000 deaths in 2020 and an age-adjusted mortality rate of 3.05 per 100,000, rank twelfth in mortality among various cancers. Our study aimed to investigate the crude rate, age-standardized mortality rate (ASMR) and the trends of brain and CNS malignancies over nine years in northern Iran.</p><p><strong>Methods: </strong>This cross-sectional study conducted a thorough analysis of mortality caused by brain and CNS cancers in Babol between the years 2013 and 2021. Death registration and classification systems at Babol University of Medical Sciences were used to collect the cause-of-death data. A census sampling method was used to determine the number of brain and CNS cancers deaths. All analyses were done using SPSS Version 22 and STATA Version 14. The significance level was set at (p<0.05). The crude and age-standardized mortality rate was calculated. The Cochran-Armitage Trend Test was utilized to determine the mortality trend.</p><p><strong>Results: </strong>The crude rates and ASMRs for brain and CNS cancers increased, from 3.3 and 3.2 per 100,000 people in 2013 to 7.0 and 6.3 per 100,000 in 2021, respectively (p < 0.001). Additionally, over the nine years, an increasing trend was explicitly observed for brain cancer (p < 0.001), while the trends for other cancers remained stable.</p><p><strong>Conclusion: </strong>The ASMR and the trend of brain and CNS cancers are on the rise. This study's findings could be beneficial for designing monitoring programs and investigating cancer risk factors.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"791-796"},"PeriodicalIF":1.0,"publicationDate":"2025-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694776/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145740786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-19eCollection Date: 2025-01-01DOI: 10.22088/cjim.16.4.731
Mohamadali Pourabbasi, Mehdi Nikkhah, Nasser Behnampour, Seyde Sedighe Yousefi
Background: Chronic tonsillitis can lead to various complications in childhood. Various treatment methods, including pharmaceutical treatments, surgery, and complementary medicine, have been used to treat it. Iranian traditional medicine has mentioned the effects of black mulberry on tonsillitis. Hence, this study aimed to investigate the effects of black mulberry syrup on tonsil hypertrophy.
Methods: This controlled clinical trial study involved 5- to 15-year-old children referred to Bu-Ali Hospital, Sari. First, 76 patients were allocated equally to the intervention or control groups using randomized blocks of four. In a three-week period, the intervention group received black mulberry syrup, whereas the control group received the placebo. Data analysis was done in SPSS Version 20, using Mann-Whitney U and McNemar tests.
Results: The study results revealed significant differences between the intervention and control groups regarding the primary outcomes of the intervention, including the size of the tonsils, oral breathing during sleep, nocturnal snoring, and hypernasal speech (P=0.001). The intervention group showed significant improvement in these symptoms compared to the control group.
Conclusion: The findings of this study suggest that black mulberry syrup effectively alleviated tonsillitis symptoms in the intervention group compared to the control group. In addition, no side effects or drug complications were reported in any study participants.
背景:儿童期慢性扁桃体炎可导致多种并发症。包括药物治疗、手术和补充医学在内的各种治疗方法已被用于治疗它。伊朗传统医学提到黑桑对扁桃体炎的作用。因此,本研究旨在探讨黑桑糖浆对扁桃体肥大的影响。方法:这项对照临床试验研究涉及5至15岁的儿童转诊到布阿里医院,沙里。首先,76名患者被随机分为干预组和对照组,每组4个。在三周的时间里,干预组服用黑桑椹糖浆,而对照组服用安慰剂。数据分析采用SPSS Version 20,采用Mann-Whitney U和McNemar检验。结果:研究结果显示,干预组和对照组在干预的主要结局方面存在显著差异,包括扁桃体的大小、睡眠时的口腔呼吸、夜间打鼾和多鼻语言(P=0.001)。与对照组相比,干预组在这些症状上有显著改善。结论:本研究结果提示干预组与对照组相比,黑桑糖浆能有效缓解扁桃体炎症状。此外,没有任何研究参与者报告副作用或药物并发症。
{"title":"Black mulberry syrup on reducing tonsillar hypertrophy and its clinical symptoms: A randomized, double-blind, controlled trial.","authors":"Mohamadali Pourabbasi, Mehdi Nikkhah, Nasser Behnampour, Seyde Sedighe Yousefi","doi":"10.22088/cjim.16.4.731","DOIUrl":"10.22088/cjim.16.4.731","url":null,"abstract":"<p><strong>Background: </strong>Chronic tonsillitis can lead to various complications in childhood. Various treatment methods, including pharmaceutical treatments, surgery, and complementary medicine, have been used to treat it. Iranian traditional medicine has mentioned the effects of black mulberry on tonsillitis. Hence, this study aimed to investigate the effects of black mulberry syrup on tonsil hypertrophy.</p><p><strong>Methods: </strong>This controlled clinical trial study involved 5- to 15-year-old children referred to Bu-Ali Hospital, Sari. First, 76 patients were allocated equally to the intervention or control groups using randomized blocks of four. In a three-week period, the intervention group received black mulberry syrup, whereas the control group received the placebo. Data analysis was done in SPSS Version 20, using Mann-Whitney U and McNemar tests.</p><p><strong>Results: </strong>The study results revealed significant differences between the intervention and control groups regarding the primary outcomes of the intervention, including the size of the tonsils, oral breathing during sleep, nocturnal snoring, and hypernasal speech (P=0.001). The intervention group showed significant improvement in these symptoms compared to the control group.</p><p><strong>Conclusion: </strong>The findings of this study suggest that black mulberry syrup effectively alleviated tonsillitis symptoms in the intervention group compared to the control group. In addition, no side effects or drug complications were reported in any study participants.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"731-740"},"PeriodicalIF":1.0,"publicationDate":"2025-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694769/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145741282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-19eCollection Date: 2025-01-01DOI: 10.22088/cjim.16.4.686
Mansour Babaei, Komeil Norouzi, Behzad Heidari
Background: Postmenopausal women with symptomatic knee osteoarthritis (KOA) may be at increased risk of bone loss due to reduced physical activity. However, findings on the association between KOA and osteoporosis have been inconsistent. This study aimed to assess the relationship between symptomatic KOA and bone mineral density (BMD) in postmenopausal women.
Methods: Postmenopausal women with symptomatic KOA were recruited from a rheumatology clinic. KOA was diagnosed according to the American College of Rheumatology (ACR) criteria. Age-matched postmenopausal women without clinical KOA served as controls. BMD at the femoral neck (FN) and lumbar spine (LS) was measured using dual-energy X-ray absorptiometry (DXA). Osteoporosis was defined as a T-score < -2.5 at either site. Statistical analyses included Student's t-test, chi-square test, and multiple regression analysis. Data were analyzed using SPSS software.
Results: Seventy participants (35 KOA patients and 35 controls) with mean ages of 61.9±8.7 and 58.8±6.8 years, respectively (P = 0.67), were included. No significant differences in BMD were found between the groups. However, multiple regression analysis revealed that obesity was significantly associated with a reduced risk of osteoporosis (OR = 0.23; 95% CI: 0.058-0.945).
Conclusion: This study found no significant association between symptomatic KOA and osteoporosis in postmenopausal women. Interestingly, obesity appeared to have a protective effect against osteoporosis. Further large-scale, long-term studies are needed to confirm these findings and explore underlying mechanisms.
{"title":"Association between osteoporosis and symptomatic knee osteoarthritis in postmenopausal women: A case-control study.","authors":"Mansour Babaei, Komeil Norouzi, Behzad Heidari","doi":"10.22088/cjim.16.4.686","DOIUrl":"10.22088/cjim.16.4.686","url":null,"abstract":"<p><strong>Background: </strong>Postmenopausal women with symptomatic knee osteoarthritis (KOA) may be at increased risk of bone loss due to reduced physical activity. However, findings on the association between KOA and osteoporosis have been inconsistent. This study aimed to assess the relationship between symptomatic KOA and bone mineral density (BMD) in postmenopausal women.</p><p><strong>Methods: </strong>Postmenopausal women with symptomatic KOA were recruited from a rheumatology clinic. KOA was diagnosed according to the American College of Rheumatology (ACR) criteria. Age-matched postmenopausal women without clinical KOA served as controls. BMD at the femoral neck (FN) and lumbar spine (LS) was measured using dual-energy X-ray absorptiometry (DXA). Osteoporosis was defined as a T-score < -2.5 at either site. Statistical analyses included Student's t-test, chi-square test, and multiple regression analysis. Data were analyzed using SPSS software.</p><p><strong>Results: </strong>Seventy participants (35 KOA patients and 35 controls) with mean ages of 61.9±8.7 and 58.8±6.8 years, respectively (P = 0.67), were included. No significant differences in BMD were found between the groups. However, multiple regression analysis revealed that obesity was significantly associated with a reduced risk of osteoporosis (OR = 0.23; 95% CI: 0.058-0.945).</p><p><strong>Conclusion: </strong>This study found no significant association between symptomatic KOA and osteoporosis in postmenopausal women. Interestingly, obesity appeared to have a protective effect against osteoporosis. Further large-scale, long-term studies are needed to confirm these findings and explore underlying mechanisms.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"686-691"},"PeriodicalIF":1.0,"publicationDate":"2025-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694791/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145741350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-18eCollection Date: 2025-01-01DOI: 10.22088/cjim.16.4.725
Reyhaneh Rezaei Ghamsari, Mohammad Shayestehpour, Ali Sobhani Nasab, Ali Nazari-Alam
Background: Zinc oxide (ZnO) nanoparticles are particularly notable in the biomedical field, especially for antimicrobial applications, due to their beneficial properties. This study aimed to investigate the antimicrobial activity of ZnO nanoparticles against Pseudomonas aeruginosa (P. aeruginosa) isolated from clinical samples.
Methods: A microdilution test was conducted to assess the effectiveness of the synthesized against P. aeruginosa. Additionally, the impact of the zinc oxide nanocomposite on the expression of biofilm-related genes, including algD, lecA, and lecB, was measured using the Real-Time PCR method.
Results: The minimum inhibitory concentration (MIC) of the ZnO nanocomposite against P. aeruginosa was found to be 625 µg/ml. At half the MIC concentration, ZnO nanoparticles demonstrated a 54% inhibition of biofilm formation. The expression levels of the algD, lecA, and lecB genes were reduced by 3.3 (p < 0.001), 1.8 (p < 0.05), and 3.1 folds (p < 0.05), respectively.
Conclusion: Overall, ZnO nanoparticles, by reducing the expression levels of the algD, LecA, and LecB genes in P. aeruginosa, can be utilized as a novel therapeutic approach to improve and treat infection-related biofilms.
{"title":"Zinc oxide nanoparticles as a new approach to eradicate the biofilm of <i>Pseudomonas aeruginosa</i> isolated from clinical samples.","authors":"Reyhaneh Rezaei Ghamsari, Mohammad Shayestehpour, Ali Sobhani Nasab, Ali Nazari-Alam","doi":"10.22088/cjim.16.4.725","DOIUrl":"10.22088/cjim.16.4.725","url":null,"abstract":"<p><strong>Background: </strong>Zinc oxide (ZnO) nanoparticles are particularly notable in the biomedical field, especially for antimicrobial applications, due to their beneficial properties. This study aimed to investigate the antimicrobial activity of ZnO nanoparticles against <i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) isolated from clinical samples.</p><p><strong>Methods: </strong>A microdilution test was conducted to assess the effectiveness of the synthesized against <i>P. aeruginosa</i>. Additionally, the impact of the zinc oxide nanocomposite on the expression of biofilm-related genes, including <i>algD</i>, <i>lecA</i>, and <i>lecB</i>, was measured using the Real-Time PCR method.</p><p><strong>Results: </strong>The minimum inhibitory concentration (MIC) of the ZnO nanocomposite against <i>P. aeruginosa</i> was found to be 625 µg/ml. At half the MIC concentration, ZnO nanoparticles demonstrated a 54% inhibition of biofilm formation. The expression levels of the <i>algD</i>, <i>lecA</i>, and <i>lecB</i> genes were reduced by 3.3 (p < 0.001), 1.8 (p < 0.05), and 3.1 folds (p < 0.05), respectively.</p><p><strong>Conclusion: </strong>Overall, ZnO nanoparticles, by reducing the expression levels of the <i>algD</i>, <i>LecA</i>, and <i>LecB</i> genes in <i>P. aeruginosa</i>, can be utilized as a novel therapeutic approach to improve and treat infection-related biofilms.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"725-730"},"PeriodicalIF":1.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694870/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145741334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-18eCollection Date: 2025-01-01DOI: 10.22088/cjim.16.4.767
Seyed Kianoosh Hosseini, Ghulam Muhammad Rind Baloch, Ali Fathi Jouzdani, Mohammad Ali Seif Rabiei, Seyed Kamaledin Hadei
Background: The relationship between epicardial fat and coronary stenosis has been a topic of recent discussion. This study aimed to determine the correlation between epicardial fat volume and coronary artery stenosis in patients undergoing CT angiography.
Methods: In this descriptive/cross-sectional study, 240 patients with low to moderate risk of CAD, referred to the CT angiography unit of Farshchian Hospital in Hamadan in 2023, were selected via the Census method. Coronary artery stenosis was assessed using a 128-slice multi-detector CT scan, while epicardial fat volume was measured using CT scan analysis. Statistical analyses were performed using SPSS software Version 21, with a significance level set at 0.05.
Results: The mean age of the patients was 54.69 years, with 52.5% being males. The mean epicardial fat volume was 76.64 ml, and 58.3% of the patients had coronary artery stenosis. The mean epicardial fat volume in patients with coronary stenosis was 82.82±31.41 ml, compared to 65.66±25.79 ml in those without stenosis (p<0.001). There was a significant positive correlation between epicardial fat volume and patients' age, calcium score, vessel score, and LDL levels. Additionally, the mean epicardial fat volume in patients with both obstructive and non-obstructive stenosis in the LAD and LCX was significantly higher than in vessels without stenosis (P < 0.05).
Conclusion: Epicardial fat volume is significantly associated with coronary artery stenosis and calcium score. Therefore, it can be utilized to determine and predict the presence and severity of coronary artery stenosis.
{"title":"CT angiography evaluation of epicardial fat volume and its association with coronary artery stenosis: A single-center cross-sectional study.","authors":"Seyed Kianoosh Hosseini, Ghulam Muhammad Rind Baloch, Ali Fathi Jouzdani, Mohammad Ali Seif Rabiei, Seyed Kamaledin Hadei","doi":"10.22088/cjim.16.4.767","DOIUrl":"10.22088/cjim.16.4.767","url":null,"abstract":"<p><strong>Background: </strong>The relationship between epicardial fat and coronary stenosis has been a topic of recent discussion. This study aimed to determine the correlation between epicardial fat volume and coronary artery stenosis in patients undergoing CT angiography.</p><p><strong>Methods: </strong>In this descriptive/cross-sectional study, 240 patients with low to moderate risk of CAD, referred to the CT angiography unit of Farshchian Hospital in Hamadan in 2023, were selected via the Census method. Coronary artery stenosis was assessed using a 128-slice multi-detector CT scan, while epicardial fat volume was measured using CT scan analysis. Statistical analyses were performed using SPSS software Version 21, with a significance level set at 0.05.</p><p><strong>Results: </strong>The mean age of the patients was 54.69 years, with 52.5% being males. The mean epicardial fat volume was 76.64 ml, and 58.3% of the patients had coronary artery stenosis. The mean epicardial fat volume in patients with coronary stenosis was 82.82±31.41 ml, compared to 65.66±25.79 ml in those without stenosis (p<0.001). There was a significant positive correlation between epicardial fat volume and patients' age, calcium score, vessel score, and LDL levels. Additionally, the mean epicardial fat volume in patients with both obstructive and non-obstructive stenosis in the LAD and LCX was significantly higher than in vessels without stenosis (P < 0.05).</p><p><strong>Conclusion: </strong>Epicardial fat volume is significantly associated with coronary artery stenosis and calcium score. Therefore, it can be utilized to determine and predict the presence and severity of coronary artery stenosis.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 4","pages":"767-774"},"PeriodicalIF":1.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12694770/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145740344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}